Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, announces the appointment of Dr. Klaus Edvardsen as its new Chief Medical ...

Sanofi announced its intention to execute a share buyback program in 2025 of €5 billion, preferably through block trades and in the open market with the purpose of cancellation. A first tranche of ...

In an industry-defining moment, Accumulus Synergy (“Accumulus”) has powered Amgen’s groundbreaking regulatory submission: the first-ever, digitally generated Chemistry, Manufacturing, and Controls ...

Clinigen, the global speciality pharmaceutical services group, and Essential Pharma, an international specialty pharmaceutical group, today announced an expansion of their JAPAC collaboration, aimed ...

Researchers have created a remarkable new map of a key part of our brain, the hypothalamus, that will lead to new ways of controlling our weight, appetite, sleep and stress levels. Health and wellness ...

Actimed Therapeutics, a UK based clinical stage speciality pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, announces today ...

Syncona Ltd (”Syncona”), a leading life science investor focused on creating, building and scaling a portfolio of global leaders in life science, today issues its quarterly update covering the period ...

Dr. Nicole Schrader provides customized solutions for eyelid asymmetry and excess skin through complex upper blepharoplasty ...

VANCOUVER, BC / ACCESS Newswire / February 6, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, ...

TORONTO, ONTARIO / ACCESS Newswire / February 6, 2025 / Smile CDR Inc. (d.b.a. Smile Digital Health), the world leader in FHIR®-based health data solutions, today announced a successful $15 million ...

ST. LOUIS, MISSOURI / ACCESS Newswire / February 6, 2025 / Leinco Technologies, a leader in antibody and protein development, is thrilled to announce that it has been awarded a $1M grant from the ...

DUBLIN, IE / ACCESS Newswire / February 6, 2025 / Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical device partners, and Innovation Zed, a ...